RecruitingPhase 3NCT03770936
Effect of Some Drugs on Liver Fibrosis
Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C
Sponsor
Sherief Abd-Elsalam
Enrollment
45 participants
Start Date
Oct 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Effect of Some Drugs on Liver Fibrosis
Eligibility
Min Age: 20 Years
Inclusion Criteria1
- chronic hepatitis C
Exclusion Criteria2
- Acute hepatitis
- Thalassemia
Interventions
DRUGCandesartan
Candesartan 8 mg/day
DRUGRamipril
ramipril 1.25 mg/day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03770936